Hepatocellular carcinoma: Difference between revisions
| Line 44: | Line 44: | ||
====Contraindicated medications==== | ====Contraindicated medications==== | ||
{{MedCondContrAbs | {{MedCondContrAbs|MedCond = Hepatocellular carcinoma|Drospirenone and Ethinyl estradiol|Norethindrone acetate and ethinyl estradiol|Norgestimate and Ethinyl estradiol}} | ||
|MedCond = Hepatocellular carcinoma|Norethindrone acetate and ethinyl estradiol}} | |||
'''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | '''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | ||
Revision as of 18:57, 23 October 2014
| Hepatocellular carcinoma | |
 | |
|---|---|
| Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein | |
| ICD-10 | C22.0 |
| ICD-9 | 155 |
| ICD-O: | 8170/3 |
| MedlinePlus | 000280 |
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma |
|
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical therapy: Percutaneous ethanol injection | Transcatheter arterial chemoembolization (TACE) | Sealed source radiotherapy | Radiofrequency ablation (RFA) | Intra-arterial iodine-131–lipiodol administration | High intensity focused ultrasound (HIFU) | Hormonal therapy | Chemotherapy
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and ethinyl estradiol
- Norgestimate and Ethinyl estradiol
Surgery: Liver transplant | Surgical resection | Cryosurgery
Prevention: Primary prevention | Secondary prevention
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology
de:Leberzellkarzinom fi:Maksasyöpä hr:Rak jetre hu:Májtumor la:Carcinoma hepatocellulare ko:간암 nl:Leverkanker no:Leverkreft sv:Levercancer